Clinical Trial Update: Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update describes a study of docetaxel plus carboplatin for patients with Stage III or IV ovarian, fallopian tube, or primary periton…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Herbert Irving Comprehensive Cancer Center | Conditions: Endometrial Cancer, Fallopian Tube Cancer | Phase 2 | Status: UNKNOWN